pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
naltrexone hydrochloride
Lodonal (naltrexone hydrochloride)
Autoimmune Hepatitis
Opioid receptors; mu/kappa/delta
Biostax Corp
0 catalysts
Phase 3
namodenoson
Hepatocellular Carcinoma
Adenosine receptor A3
$CANFCan-Fite BioPharma Ltd.
0 catalysts
Preclinical
nanoencorafenib
Colorectal Cancer
Nanoform Finland Plc
← prev
page 234 of 271
next →
131
Pain89
Neurology1
0 catalysts
Phase 3
nanvuranlat
nanvuranlat [INN]
Metastatic Biliary Tract Cancer
J-Pharma Co Ltd
0 catalysts
Phase 3
napazimone
Mitochondrial Diseases
Abliva AB
0 catalysts
Preclinical
naproxcinod
Sickle Cell Disease With Vaso-Occlusive Crisis
Fera Pharmaceuticals LLC
0 catalysts
Marketed
naproxen DR
Naproxen (naproxen)
Ankylosing Spondylitis (Bekhterev's Disease)
NuCare Pharmaceuticals Inc
0 catalysts
Marketed
naproxen sodium ER
Naproxen Sodium Alvogen (naproxen sodium)
Primary Dysmenorrhea
Alvogen Inc
0 catalysts
Marketed
naratriptan hydrochloride
Naratriptan (naratriptan hydrochloride)
Migraine
Orchid Pharma Inc
0 catalysts
Phase 2
narmafotinib tartrate
Metastatic Adenocarcinoma of The Pancreas
Amplia Therapeutics Ltd
0 catalysts
Phase 2
naronapride
Diabetic Gastroparesis
5-hydroxytryptamine receptor 4
Renexxion LLC
0 catalysts
Marketed
natalizumab
Tysabri (natalizumab)
Crohn's Disease (Regional Enteritis)
$BIIBBIOGEN INC.
0 catalysts
Marketed
natamycin
Natacyn (natamycin)
Blepharitis
$HROWHARROW, INC.
0 catalysts
Marketed
nateglinide
Nateglinide (nateglinide)
Type 2 Diabetes
Modavar Pharmaceuticals LLC
0 catalysts
Phase 3
navacaprant hydrochloride
Major Depressive Disorder
$NMRANeumora Therapeutics, Inc.
0 catalysts
Phase 3
navenibart
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)
$BCRXBIOCRYST PHARMACEUTICALS INC
0 catalysts
Phase 2
navicixizumab
Fallopian Tube Cancer
Feng Biosciences Inc
0 catalysts
Phase 3
navitoclax dihydrochloride
Myelofibrosis
$ABBVAbbVie Inc.
0 catalysts
Phase 2
navtemadlin
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Tumour suppressor p53/oncoprotein Mdm2
Kartos Therapeutics Inc
0 catalysts
Phase 2
naxitamab
Danyelza (naxitamab-gqgk)
Neuroblastoma
Y-mAbs Therapeutics Inc
0 catalysts
Phase 3
naxtarubicin
Refractory Acute Myeloid Leukemia
$MBRXMoleculin Biotech, Inc.
0 catalysts
Marketed
nebivolol hydrochloride
Nebivolol Hydrochloride (nebivolol hydrochloride)
Hypertension
Beximco Pharmaceuticals USA Inc
0 catalysts
Phase 2
nebokitug
Primary Sclerosing Cholangitis
$CMMBChemomab Therapeutics Ltd.
0 catalysts
Marketed
necitumumab
Portrazza (necitumumab)
Squamous Non-Small Cell Lung Cancer
Eli Lilly and Co
0 catalysts
Preclinical
nedaplatin
nedaplatin [INN]
Esophageal Cancer
RNR BioMedical Inc
0 catalysts
Phase 2
nedometinib
Neurofibromatoses Type I (Von Recklinghausen's Disease)
NFlection Therapeutics Inc
0 catalysts
Marketed
nedosiran sodium
Rivfloza (nedosiran sodium)
Primary Hyperoxaluria Type II
L-lactate dehydrogenase A chain mRNA
Novo Nordisk AS
0 catalysts
Marketed
nefazodone hydrochloride
Nefazodone Hydrochloride (nefazodone hydrochloride)
Major Depressive Disorder
Teva Pharmaceuticals USA Inc
0 catalysts
Phase 2
neflamapimod
Frontotemporal Dementia (Pick Disease)
Mitogen-activated protein kinase 14
$CRVOCervoMed Inc.
0 catalysts
pre_registration
neladalkib
Non-Small Cell Lung Cancer
$NUVLNuvalent, Inc.
0 catalysts